Moreover, TNF, TNFR2, and EBi3 are up-regulated only in DR-TB patients after 6 months of anti-TB therapy, suggesting that DR-TB treatment is slower than DS-TB therapy to regulate the expression of molecules necessary to modulate the inflammatory process. The gene discussed is EBI3; the disease is tuberculosis.